Chikungunya isn't prevalent in the U.S., but travelers are being told to be cautious about getting the vaccine for the ...

The U.S. Department of Health and Human Services is planning to drop CDC recommendations for routine Covid-19 vaccines for ...

Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...

FDA Commissioner Marty Makary said his agency plans to release a new framework for vaccine approvals in “coming days.” ...

The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...

Chikungunya is transmitted to humans through the bite of infected female mosquitoes, particularly Aedes aegypti and Aedes ...

RFK Jr. faced a bipartisan committee of House representatives, charged with questioning him on proposals for sweeping funding ...

The decision follows ongoing investigations into serious adverse events primarily reported in elderly individuals who ...

The U.S. government is advising that international travelers age 60 and older not get a chikungunya vaccine as it ...

A vaccine designed to protect against chikungunya, a mosquito-borne illness, has been temporarily paused for individuals aged 60 and older.

The Trump administration is planning to drop recommendations that pregnant women, teenagers and children get Covid-19 ...

The CDC recommends the vaccine pause while it investigates “serious adverse events,” including neurologic and cardiac events.